SOURCE: CryoPort, Inc.

May 20, 2008 09:40 ET

CryoPort, Inc. to Present at the Ludlow Biotech Investor Conference in New York City

LAKE FOREST, CA--(Marketwire - May 20, 2008) - CryoPort, Inc. (OTCBB: CYRX), a company developing leading edge, proprietary, technology-driven shipping and storage products for use in the rapidly growing global biotechnology and biopharmaceutical cold chain, today announced plans for the company to present at the Ludlow Biotech Investor Conference Thursday, May 22, 2008.

The conference will be held at the New York Helmsley Hotel in New York City, between 5pm to 8pm EDT.

Investors interested in attending can register online here -- http://www.ludlowcapital.com/events/attend.html

About Ludlow Biotech Ventures, Inc.

Headquartered in Manhattan, Ludlow BioVentures, Inc. is a full service investment advisory firm which serves the needs of both private and public biotechnology companies. Our simple approach is to provide customized financial solutions for virtually any of our clients needs. www.ludlowcapital.com/bioventures/

About CryoPort, Inc.

CryoPort's mission is to provide the most cost effective packaging system that ensures conservation of temperature sensitive biological materials that are critical to the expanding biopharmaceutical and biotechnology industries. CryoPort is dedicated to producing superior, affordable cryogenic shipping systems that maintains the integrity of scientific research advanced by the growing biopharma and biotech industries. CryoPort understands the value of such research and is committed to evolving cryogenic shipping as a new industry standard globally for temperature sensitive materials; such as life-sustaining vaccines and other medical research that are used in clinical trials around the world.

"SAFE HARBOR"

This press release contains forward-looking statements. The words "estimate," "possible" and "seeking" and similar expressions identify forward-looking statements, which speak only as to the date the statement was made. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether because of new information, future events, or otherwise. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted, or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks.

Contact Information

  • Contact:
    Stuart Fine
    CEO
    Carpe DM, Inc.
    908-469-1788

    Thomas Latino, PhD
    Ludlow BioVentures
    Phone: (201) 245-4278
    Email: tlatino@ludlowcapital.com